➀ Samsung is making significant progress in developing a non-invasive continuous glucose monitor; ➁ The technology is expected to be a game-changer for diabetes monitoring; ➂ Samsung's executive hints at a non-invasive optically-based continuous glucose monitor for the Galaxy Watch.

➀ Diabetes is now among the top ten causes of death globally; ➁ 537 million people suffer from diabetes worldwide in 2021; ➂ The number of adults with diabetes is projected to increase to 787 million by 2045.

1. Novo Nordisk remains a sell due to increased competition and regulatory risks despite its leadership in the diabetes and weight-loss markets. 2. Hims & Hers anticipates selling a generic version of NVO's liraglutide, threatening sales as soon as next year. 3. Intense competition from Viking Therapeutics and Amgen may result in a new best-in-class GLP-1 drug, further threatening Novo's market position.

1. The National Diabetes Strategy (NDS) has been awaiting implementation for 4 years since its inception in 2020; 2. The Deutsche Diabetes Gesellschaft (DDG) and diabetesDE call for the immediate reintroduction of the NDS into the national health agenda; 3. The Bundesgesundheitsministerium (BMG) is criticized for focusing on individual measures rather than a holistic approach to combat diabetes and related diseases.